Commencement of dealings

Quintessentially English PLC
19 September 2006



QUINTESSENTIALLY ENGLISH PLC ('QE' OR THE 'COMPANY')


COMMENCEMENT OF DEALINGS


Quintessentially English PLC (to be re-named Omega Diagnostics Group PLC)
announces that it has completed inter alia the acquisition of Omega Diagnostics
Limited, a £1 million placing of new ordinary shares and an issue of warrants to
existing shareholders in the Company.  Its ordinary shares are due to be
readmitted to trading on AIM today.

Highlights

•   Acquisition of Omega Diagnostics Limited, a UK company specialising in 
    in-vitro diagnostics test kits and related products through a distribution 
    network in more than 100 countries

•   £1 million new equity (before expenses) raised via a cash placing of 
    50,000,000 New Ordinary Shares at 2p per share

•   Issue of 5,588,432 QE Warrants to existing Shareholders to subscribe for 
    Ordinary Shares at an exercise price of 2p per share

•   Appointment of a new management team from Omega Diagnostics Limited: 
    Andrew Shepherd, Chief Executive, Kieron Harbinson, Finance Director,
    David Evans, Non-executive Chairman; Michael Gurner continues as a 
    Non-executive Director

•   The Acquisition furthers Omega's strategy to become a leading in-vitro 
    diagnostics company - its strategy is to grow through selective acquisitions

Andrew Shepherd, Chief Executive, commented:

'The purchase of Omega Diagnostics Limited continues our aim to acquire
companies within the medical diagnostics sector and positions us as a key player
in the in-vitro diagnostics kit market.  Our strategy is to grow by acquisition
and to build our portfolio of products which we are already distributing
throughout  the UK and in over 100 countries worldwide.'

On completion, the Company will be paying a maximum consideration of £3 million
of which approximately £1.2 million will be satisfied by the issue of 60,600,000 
New Ordinary Shares and the balance of up to approximately £1.8 million as 
deferred consideration to be satisfied by way of up to 89,400,000 Earn Out 
Shares at a minimum issue price of 2p per share subject to certain earn out 
targets being met for the financial year ending 31 March 2008.

Immediately following admission, the issued share capital of the Company will 
be 121,776,865 Ordinary Shares.



For further information, please contact:  

Quintessentially English PLC 
(to be re-named Omega Diagnostics Group PLC) - 01259 763 030


Andrew Shepherd
Chief Executive


Kieron Harbinson
Finance Director


City Financial Associates Limited - 020 7090 7800


Barry Saint
Director


END


                      This information is provided by RNS
            The company news service from the London Stock Exchange